Matrix One

Status
Current portfolio
Investment type
Growth Buy-out
Investment date
June 2022
Location
Germany

Matrix One (formerly Matrix Requirements) is a global leader in software solutions for medical device manufacturers (Medical Devices and Software as/in Medical Device – SxMD) and life sciences companies. Their mission is to help innovative organizations develop safer products, faster, while simplifying regulatory compliance.

Their intuitive, flexible, AI-powered solutions ensure quality and traceability across the entire product lifecycle.

Matrix One’s solutions

  • Matrix Req: A design control software for product development teams, with advanced AI capabilities to support requirements management, quality oversight, risk management, and regulatory standards compliance. Matrix Req works seamlessly with Matrix QMS to provide full traceability and smooth integration with quality processes.
  • Matrix QMS (formerly Simploud): A compliant cloud-based quality management system that enables organizations to manage all quality processes, from audits to CAPA, incident and document management. Matrix QMS and Matrix Req together link design and quality, providing a comprehensive view of the product lifecycle.
  • Matrix Connect (formerly Galen Data): A secure, compliant cloud solution designed for connected medical devices, enabling seamless data collection, management, and protection.
  • Matrix eIFU (formerly Dokspot): A fully compliant electronic Instructions For Use (eIFU) solution enabling manufacturers to securely publish, manage, and update electronic documentation in multiple languages, in line with global regulatory requirements.

Founded in 2015 by medical device experts, Matrix One now has a team of over 40 employees based across Germany, France, Belgium, the United Kingdom, the United States, and Spain.

Yves and Wolfgang have built remarkable MedTech quality management system products that delight customers and accelerate time to market for life saving medical devices. The MedTech eQMS software market exceeds $2.5 billion in size and is growing rapidly as software replaces paper and regulatory scrutiny grows. We are excited to work hand in hand with the Matrix management team to strengthen the company’s commercial engine and enable our customers to navigate rigorous audits without non-conformities.

Samuel LevyCo-founding Partner at Lauxera
Acandis

Acandis

Neurovascular medical devices — Lauxera Growth II
Antaros Medical

Antaros Medical

Imaging drug development — Lauxera Growth II
BioLamina

BioLamina

Regenerative medicine tools — Lauxera Growth I
Caresyntax

Caresyntax

Surgical intelligence platform — Lauxera Growth I
Lifen

Lifen

Digital health integration — Lauxera Growth I
LUMICKS

LUMICKS

Protein and cell analysis — Lauxera Growth I
Natural Cycles

Natural Cycles

Non-hormonal contraception — Lauxera Growth I
OrganOx

OrganOx

Liver transplant optimization — Lauxera Growth I
Ospi

Ospi

Healthtech data intelligence — Lauxera Growth I
Reapplix

Reapplix

Advanced wound care — Lauxera Growth I
Synovo Group

Synovo Group

Patient transportation software — Lauxera Growth I
Veranex

Veranex

Medtech innovation services — Lauxera Growth I
Verdot

Verdot

Bioprocess purification platforms — Lauxera Growth I